SFCAs help fuel colon cells and protect against diseases like colorectal cancer and inflammatory bowel disease
Retatrutide (CAS 2381089-83-2) is a triple-agonist peptide that engages three receptors simultaneously the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor making it one of the most-studied multi-receptor metabolic peptides currently in the research literature
4 (2014): 269-75, Centers for Disease Control and Prevention, What Is Fentanyl?, last modified March 19, 2020, M.S
Proc Natl Acad Sci USA 90(15):72407244 Snchez-Pernaute R, Ferree A, Cooper O, Yu M, Brownell AL, Isacson O (2004) Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease